Stocks to invest in – 13D Filing: Avista Capital Partners Gp, Llc and Angiodynamics Inc (NASDAQ:ANGO)



Stocks to invest in

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Avista Capital Partners GP 0 2,333,008 0 2,333,008 2,333,008 6.3%
Avista Capital Partners 0 1,446,413 0 1,446,413 1,446,413 3.9%
Avista Capital Partners (Offshore) 0 381,406 0 381,406 381,406 1.0%
Navilyst Medical Co-Invest 0 505,189 0 505,189 505,189 1.4%

Page 1 of 8 – SEC Filing

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 


SCHEDULE 13D

(Rule 13d-101)

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)*

 

 

AngioDynamics, Inc.

(Name of Issuer)

Common
Stock, par value $0.01 per share

(Title of Class of Securities)

03457V101

(CUSIP Number)

Ben Silbert, Esq.

65 East 55th Street, 18th Floor

New York, NY 10022

(212) 593-6900

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

With a copy to:

Craig E. Marcus, Esq.

Ropes & Gray LLP

Prudential Tower, 800 Boylston Street

Boston, MA 02199-3600

April 12, 2017

(Date of Event Which Requires Filing of This Statement)

 

 

If the filing
person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ☐

[Note: Schedules filed in paper format shall
include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.]

* The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information
which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page
shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).

Follow Angiodynamics Inc (NASDAQ:ANGO)

Trade (NASDAQ:ANGO) Now!

– Stocks to invest in

Learn How To Be #1 on Google Results



Source link